- Home
- BPMC vs PFSI Comparison
BPMC vs PFSI Comparison
Compare BPMC & PFSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPMC
- PFSI
- Stock Information
- Founded
- BPMC 2008
- PFSI 2008
- Country
- BPMC United States
- PFSI United States
- Employees
- BPMC N/A
- PFSI N/A
- Industry
- BPMC Biotechnology: Pharmaceutical Preparations
- PFSI Finance: Consumer Services
- Sector
- BPMC Health Care
- PFSI Finance
- Exchange
- BPMC Nasdaq
- PFSI Nasdaq
- Market Cap
- BPMC 5.8B
- PFSI 4.9B
- IPO Year
- BPMC 2015
- PFSI 2013
- Fundamental
- Price
- BPMC $97.17
- PFSI $97.62
- Analyst Decision
- BPMC Buy
- PFSI Buy
- Analyst Count
- BPMC 21
- PFSI 6
- Target Price
- BPMC $124.05
- PFSI $121.17
- AVG Volume (30 Days)
- BPMC 973.2K
- PFSI 369.2K
- Earning Date
- BPMC 05-01-2025
- PFSI 04-22-2025
- Dividend Yield
- BPMC N/A
- PFSI 1.22%
- EPS Growth
- BPMC N/A
- PFSI 123.72
- EPS
- BPMC N/A
- PFSI 6.51
- Revenue
- BPMC $562,121,000.00
- PFSI $3,386,736,000.00
- Revenue This Year
- BPMC $44.85
- PFSI N/A
- Revenue Next Year
- BPMC $32.06
- PFSI $16.17
- P/E Ratio
- BPMC N/A
- PFSI $15.06
- Revenue Growth
- BPMC 99.19
- PFSI 66.25
- 52 Week Low
- BPMC $73.04
- PFSI $85.74
- 52 Week High
- BPMC $121.90
- PFSI $119.13
- Technical
- Relative Strength Index (RSI)
- BPMC 59.54
- PFSI 51.21
- Support Level
- BPMC $87.03
- PFSI $95.31
- Resistance Level
- BPMC $104.86
- PFSI $100.00
- Average True Range (ATR)
- BPMC 3.86
- PFSI 2.76
- MACD
- BPMC 1.24
- PFSI 0.45
- Stochastic Oscillator
- BPMC 64.38
- PFSI 60.10
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.
About PFSI PennyMac Financial Services Inc.
PennyMac Financial Services Inc is a specialty financial services firm with a comprehensive mortgage platform and integrated business focused on the production and servicing of U.S. residential mortgage loans. The company operates through two segments: production and servicing. The production segment performs loan origination, acquisition and sale activities. The servicing segment performs loan servicing for newly originated loans.